Literature DB >> 15083759

Remission of respiratory symptoms by smoking and occupational exposure in a cohort study.

T M L Eagan1, A Gulsvik, G E Eide, P S Bakke.   

Abstract

Few studies have estimated the remission rates of respiratory symptoms in general populations. No community cohort studies have examined the impact of smoking cessation and previous dust or fumes exposure on the remission of respiratory symptoms. In the Hordaland County Study, an 11-yr community cohort (1985-1996/1997) from Western Norway, data from 2,819 subjects were used to examine the remission of six respiratory symptoms. The measured cumulative remission varied from 42.3% for morning cough to 58.4% for chronic cough. Smoking cessation was a significant predictor of remission of the cough symptoms and wheezing, with odds ratios (OR) (95% confidence intervals (CI)) varying from 2.2 (1.3-3.7) for wheezing to 6.2 (3.5-11.2) for morning cough, after adjustment for sex, age, pack-years smoked, previous dust or fumes exposure, and educational level. In those not previously exposed to dust or fumes, the adjusted OR (95% CI) for the remission of morning cough, phlegm cough, dyspnoea grade 2, attacks of dyspnoea and wheezing varied from 1.5 (0.9-2.5) for attacks of dyspnoea to 2.1 (1.1-3.9) for dyspnoea grade 2, as compared to those previously exposed to dust or fumes. This study suggests a beneficial effect of smoking cessation and an adverse effect of occupational exposure on the remission of respiratory symptoms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083759     DOI: 10.1183/09031936.04.00041204

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia.

Authors:  A Frostad; V Soyseth; T Haldorsen; A Andersen; A Gulsvik
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

2.  Genome-wide association study identifies BICD1 as a susceptibility gene for emphysema.

Authors:  Xiangyang Kong; Michael H Cho; Wayne Anderson; Harvey O Coxson; Nestor Muller; George Washko; Eric A Hoffman; Per Bakke; Amund Gulsvik; David A Lomas; Edwin K Silverman; Sreekumar G Pillai
Journal:  Am J Respir Crit Care Med       Date:  2010-08-13       Impact factor: 21.405

3.  Respiratory symptoms and cardiovascular causes of deaths: A population-based study with 45 years of follow-up.

Authors:  Knut Stavem; Henrik Schirmer; Amund Gulsvik
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

4.  West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma.

Authors:  Jan Lötvall; Linda Ekerljung; Erik P Rönmark; Göran Wennergren; Anders Lindén; Eva Rönmark; Kjell Torén; Bo Lundbäck
Journal:  Respir Res       Date:  2009-10-12

5.  Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease.

Authors:  Philippe Gagnon; Richard Casaburi; Didier Saey; Janos Porszasz; Steeve Provencher; Julie Milot; Jean Bourbeau; Denis E O'Donnell; François Maltais
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

6.  Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time.

Authors:  Knut Stavem; Ane Johannessen; Rune Nielsen; Amund Gulsvik
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

7.  Prevalence of asthma-like symptoms with ageing.

Authors:  Debbie Jarvis; Roger Newson; Christer Janson; Angelo Corsico; Joachim Heinrich; Josep M Anto; Michael J Abramson; Anne-Marie Kirsten; Jan Paul Zock; Roberto Bono; Pascal Demoly; Bénédicte Leynaert; Chantal Raherison; Isabelle Pin; Thorarinn Gislason; Rain Jogi; Vivi Schlunssen; Cecilie Svanes; John Watkins; Joost Weyler; Antonio Pereira-Vega; Isabel Urrutia; Jose A Gullón; Bertil Forsberg; Nicole Probst-Hensch; H Marike Boezen; Jesús Martinez-Moratalla Rovira; Simone Accordini; Roberto de Marco; Peter Burney
Journal:  Thorax       Date:  2017-10-03       Impact factor: 9.139

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.